Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

CMV Status Predicts Survival in Refractory/Relapsed Myeloid Patients after a Clofarabine-Based Sequential Regimen: A Retrospective Study on Behalf of the SFGM-TC

Amandine Le Bourgeois, PhD, Myriam Labopin, MD PhD, Felipe Suarez, MD PhD, Regis Peffault De Latour, MD PhD, Didier Blaise, Sylvain Chantepie, Stephanie Nguyen-Quoc, Natacha Maillard, MD, Reza Tabrizi, MD, Ibrahim Yakoub-Agha, Anne Huynh, MD, Tony Marchand, Karin Bilger, Patrice Ceballos, MD, Amandine Charbonnier, Pascal Turlure, MD, Mohamad Mohty, MD PhD, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 3217.

https://doi.org/10.1182/blood.V130.Suppl_1.3217.3217

Published: 2017

Journal Articles

Transplant Outcome for Secondary Acute Myeloid Leukemia Based on Prior Hematological Disease or Solid Malignancy — on Behalf of the ALWP of the EBMT

Blood (2017) 130 (Supplement 1): 3320.

https://doi.org/10.1182/blood.V130.Suppl_1.3320.3320

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Blood (2017) 130 (Supplement 1): 595.

https://doi.org/10.1182/blood.V130.Suppl_1.595.595

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Marina Diaz Beya, MD, Myriam Labopin, MD PhD, Johan Maertens, Alijurf Mahmoud, MD, Alois Gratwohl, MD, Dietrich W Beelen, MD PhD, Harry C. Schouten, MD, Gérard Socié, MDPhD, Antonius VMB Schattenberg, MD PhD, Rainer Schwerdtfeger, MD, Liisa Volin, Mauricette Michallet, MD PhD, Emmanuelle Polge, Mohamad Mohty, MD PhD, Jordi Esteve, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 596.

https://doi.org/10.1182/blood.V130.Suppl_1.596.596

Published: 2017

Journal Articles

Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC

Amandine Le Bourgeois, PhD, Myriam Labopin, MD PhD, Sebastien Maury, MD PhD, Regis Peffault De Latour, MD PhD, Jean-Henri Bourhis, Patrice Ceballos, MD, Sylvie François, Karin Bilger, Didier Blaise, Thierry Guillaume, MD PhD, Mohamad Mohty, MD PhD, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 1952.

https://doi.org/10.1182/blood.V130.Suppl_1.1952.1952

Published: 2017

Journal Articles

The Use of Anti-Thymocyte Globulin Is Associated with Decreased Risk of Chronic Graft-Versus-Host Disease without Impact on Survival after Allogeneic Peripheral Blood Stem Cell Transplantation for Adults with Philadelphia-Positive Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT

Blood (2017) 130 (Supplement 1): 1971.

https://doi.org/10.1182/blood.V130.Suppl_1.1971.1971

Published: 2017

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Siblings Versus Unmanipulated Haploidentical Donors in Relapsing or Refractory Acute Myeloid Leukemia: A Retrospective Study from the ALWP of the EBMT

Giorgia Battipaglia, MD, Ariane Boumendil, Myriam Labopin, MD PhD, Annalisa Ruggeri, MD, Fabio Ciceri, MD, Johanna Tischer, MD, Matthias Stelljes, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Jürgen Finke, MD, Maria Teresa van Lint, Arnold Ganser, MD, Boris Afanasiev, Renato Fanin, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 2027.

https://doi.org/10.1182/blood.V130.Suppl_1.2027.2027

Published: 2017

Journal Articles

Selecting between HLA-Matched Siblings and HLA- Haploidentical Related Donors for Acute Leukemia in the Era of Post-Transplant Cyclophosphamide: The Center for International Blood and Marrow Transplant Registry and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant

Blood (2017) 130 (Supplement 1): 851.

https://doi.org/10.1182/blood.V130.Suppl_1.851.851

Published: 2017

Journal Articles

Haploidentical T-Repleted Stem Cell Transplantation (SCT) Has Comparable Survival to 10/10 and 9/10 Unrelated SCT in Poor-Cytogenetics Risk Acute Myeloid Leukemia in First Complete Remission: A Study on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Francesca Lorentino, MD, Myriam Labopin, MD PhD, Fabio Ciceri, MD, Massimo Bernardi, MD, Jordi Esteve, MD, Liisa Volin, Ibrahim Yakoub-Agha, Charles Craddock, Jakob R. Passweg, MDMS, Gerard Socie, MD PhD, Jan J Cornelissen, Didier Blaise, Tobias Gedde-Dahl, MD PhD, Nathalie Fegueux, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 852.

https://doi.org/10.1182/blood.V130.Suppl_1.852.852

Published: 2017

Journal Articles

Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study

Blood (2017) 130 (Supplement 1): 907.

https://doi.org/10.1182/blood.V130.Suppl_1.907.907

Published: 2017

Journal Articles

Outcomes of Graft Failures after Umbilical Cord Blood Transplantation in Acute Leukemia: A Study from Eurocord and the Acute Leukemia Working Party of the EBMT

Frederic Baron, Annalisa Ruggeri, MD, Eric Beohou, Myriam Labopin, MD PhD, Mohamad Mohty, MD PhD, Jaime Sanz, Riccardo Saccardi, Patrice Chevallier, MD, Mauricette Michallet, MD PhD, Jean-Henri Bourhis, Christelle M Ferra Coll, William Arcese, MD, Eliane Gluckman, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 661.

https://doi.org/10.1182/blood.V130.Suppl_1.661.661

Published: 2017

Journal Articles

Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, Eric Beohou, Myriam Labopin, MD PhD, William Arcese, MD, Francesca Bonifazi, Polina Stepensky, Mahmoud Aljurf, Benedetto Bruno, Pietro Pioltelli, MD, Jakob R. Passweg, MDMS, Gerard Socie, MD PhD, Stella Santarone, Ibrahim Yakoub-Agha, Bipin N. Savani, MD, Mohamad Mohty, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 4568.

https://doi.org/10.1182/blood.V130.Suppl_1.4568.4568

Published: 2017

Journal Articles

Impact of Pre-Emptive Rituximab Treatment for Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Longitudinal Study of 110 Patients

Nicolas Stocker, MD, Myriam Labopin, MD PhD, Inès Boussen, MD, Baptiste Lamarthée, PhD, Florent Malard, MDPhD, Agnès Bonnin, Vincent Marechal, PhD, Corinne Amiel, MD, Frédérique Quignon, PhD, Joël Gozlan, MD, Giorgia Battipaglia, MD, Remy Duléry, MD, Federica Giannotti, MD, Annalisa Ruggeri, MD, Béatrice Gaugler, PhD, Mohamad Mohty, MD PhD, Eolia Brissot, MDPhD

Blood (2017) 130 (Supplement 1): 4519.

https://doi.org/10.1182/blood.V130.Suppl_1.4519.4519

Published: 2017

Journal Articles

Fractionated Gemtuzumab Ozogamicin in Association with High Dose Chemotherapy: A Bridge to Allogeneic Stem Cell Transplantation in Refractory and Relapsed Acute Myeloid Leukemia?

Pierre-Edouard Debureaux, Myriam Labopin, MD PhD, Simona Lapusan, MD, Francoise Isnard, PhD, Rosa Adaeva, Agnès Bonnin, Pierre Hirsch, MDPhD, Francois Delhommeau, MD PhD, Giorgia Battipaglia, MD, Remy Duléry, MD, Federica Giannotti, MD, Florent Malard, MDPhD, Annalisa Ruggeri, MD, Anne Vekhoff, Ollivier Legrand, MD PhD, Mohamad Mohty, MD PhD, Eolia Brissot, MDPhD

Blood (2017) 130 (Supplement 1): 4603.

https://doi.org/10.1182/blood.V130.Suppl_1.4603.4603

Published: 2017

Journal Articles

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Florent Malard, MDPhD, Myriam Labopin, MD PhD, Christina Cho, MD, Didier Blaise, Esperanza B. Papadopoulos, MD, Jakob R. Passweg, MDMS, Richard O'Reilly, MD, Noel Milpied, Molly Maloy, MS, Liisa Volin, H.R. Castro-Malaspina, MD, Yosr Hicheri, Ann A. Jakubowski, MD PhD, Sylvie François, Sergio A. Giralt, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 4564.

https://doi.org/10.1182/blood.V130.Suppl_1.4564.4564

Published: 2017

Journal Articles

The Measurable Residual Disease Status of Acute Myeloid Leukemia in First Complete Remission at Allogeneic Hematopoietic Cell Transplantation Interacts with Conditioning Intensity to Predict Outcome

Maria Helena H. Gilleece, MD FRCPath, MB, BSc, FRCP, Myriam Labopin, MD PhD, Ibrahim Yakoub-Agha, Liisa Volin, Gerard Socie, MD PhD, Per Ljungman, Anne Huynh, MD, Eric Deconinck, MD PhD, Depei Wu, MD, Jean-Henri Bourhis, Mohamad Mohty, MD PhD, Jean-Yves Cahn, Emmanuelle Polge, Audrey Mailhol, MSc, Bipin N. Savani, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 522.

https://doi.org/10.1182/blood.V130.Suppl_1.522.522

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)

Blood (2017) 130 (Supplement 1): 669.

https://doi.org/10.1182/blood.V130.Suppl_1.669.669

Published: 2017

Journal Articles

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Conditioning in Adults with Acute Lymphoblastic Leukemia in Remission: Peripheral Blood or Bone Marrow?.

Nadezda Basara, MD, DSc, Myriam Labopin, MD, PhD, Tapani Ruutu, MD, Axel Zander, MD, Oliver Ottmann, MD, Renate Arnold, MD, Vanderson Rocha, MD

Blood (2007) 110 (11): 174.

https://doi.org/10.1182/blood.V110.11.174.174

Published: 2007

Journal Articles

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Preparative Regimen for Adult Patients with Acute Lymphoblastic Leukemia in CR: A Survey from the European Group for Blood and Marrow Transplantation (EBMT).

Nadezda Basara, MD, DSc, Myriam Labopin, MD, PhD, Tapani Ruutu, MD, Axel Zander, MD, Renate Arnold, MD, Vanderson Rocha, MD, PhD

Blood (2006) 108 (11): 3112.

https://doi.org/10.1182/blood.V108.11.3112.3112

Published: 2006

Journal Articles

Phenotypic Description of Familial Chronic Myeloproliferative Disorders.

Albert Najman, MD, Isabelle Chaumarel, MD, Christine Bellann-Chantelot, PharmD., Ph.D., Veronique Barbu, MD,PhD, Myriam Labopin, MD,PhD, Jean D. Rain, MD,PhD, Nicole Casadevall, MD, Bruno Varet, MD, Francis Bauters, MD, Gilles Thomas, MD,PhD

Blood (2004) 104 (11): 658.

https://doi.org/10.1182/blood.V104.11.658.658

Published: 2004

NARROW

CMV Status Predicts Survival in Refractory/Relapsed Myeloid Patients after a Clofarabine-Based Sequential Regimen: A Retrospective Study on Behalf of the SFGM-TC

Transplant Outcome for Secondary Acute Myeloid Leukemia Based on Prior Hematological Disease or Solid Malignancy — on Behalf of the ALWP of the EBMT

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Siblings Versus Unmanipulated Haploidentical Donors in Relapsing or Refractory Acute Myeloid Leukemia: A Retrospective Study from the ALWP of the EBMT

Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study

Outcomes of Graft Failures after Umbilical Cord Blood Transplantation in Acute Leukemia: A Study from Eurocord and the Acute Leukemia Working Party of the EBMT

Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Impact of Pre-Emptive Rituximab Treatment for Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Longitudinal Study of 110 Patients

Fractionated Gemtuzumab Ozogamicin in Association with High Dose Chemotherapy: A Bridge to Allogeneic Stem Cell Transplantation in Refractory and Relapsed Acute Myeloid Leukemia?

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

The Measurable Residual Disease Status of Acute Myeloid Leukemia in First Complete Remission at Allogeneic Hematopoietic Cell Transplantation Interacts with Conditioning Intensity to Predict Outcome

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Conditioning in Adults with Acute Lymphoblastic Leukemia in Remission: Peripheral Blood or Bone Marrow?.

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Preparative Regimen for Adult Patients with Acute Lymphoblastic Leukemia in CR: A Survey from the European Group for Blood and Marrow Transplantation (EBMT).

Phenotypic Description of Familial Chronic Myeloproliferative Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only